We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Bacteria Could Help Build Better Bone Replacements

By HospiMedica International staff writers
Posted on 21 Sep 2009
Serratia bacteria, which manufacture nanoscale hydroxyapatite (HA), could be used to make stronger, more durable bone implants, claims a new study.

Researchers from the University of Birmingham (UK) have shown that when challenged with a solution containing calcium chloride and phosphatase substrate, Serratia bacteria manufactures a biofilm containing biopolymers that adhered tightly to different surfaces, such as titanium alloy, polypropylene, porous glass, and polyurethane foam. More...
The biofilm-bound material was identified as containing HA, a coating of which then builds up over the surface. This HA biocoating method is able to reach hidden recesses and surfaces that the bacteria can reach, but that regular industrial processes cannot. The bacterial HA also has better properties than HA that is manufactured chemically, since the nanocrystals of HA produced are much smaller, giving them a high mechanical strength.

For practical use, the materials need to be dried and heated to destroy the Serratia bacteria. Testing bond strength showed that dried biofilm bond to the surfaces was 20-times stronger than fresh biofilm. When coating with HA was completed, the adhesion was several times higher again; and slightly roughening the surfaces made the bioglue much more effective. The study was presented at the Society for General Microbiology's annual meeting, held during September 2009 in Edinburgh (UK).

"The bacteria are destroyed by heating, leaving just the HA stuck to the surface with their own glue--rather akin to a burnt milk-saucepan," said study presenter Prof. Lynne Macaskie, Ph.D., of the school of biosciences. "We need to do more work actually to turn the materials into materials we can use in biomedicine and the environment. Then they need to be tested in real life situations with clinical and environmental trials."

Serratia
is a genus of Gram-negative, facultatively anaerobic, rod-shaped bacteria of the Enterobacteriaceae family. Members of this genus produce characteristic red pigment called prodigiosin.

University of Birmingham



Related Links:

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Open Stapler
PROXIMATE Linear Cutter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.